Answers are grounded in this paper and cite their sources.
Wound healing after tooth extraction is a complex process requiring precise molecular regulation. Bone Morphogenetic Protein-2 (BMP-2) promotes osteogenesis, while Tumor Necrosis Factor-alpha (TNF-α) mediates inflammation. Secretome derived from Stem Cells from Human Exfoliated Deciduous Teeth (SHED) offers a promising cell-free therapy for post-extraction healing, potentially modulating these key molecules. This study aimed to quantify BMP-2 and TNF-α levels in SHED secretome gel and evaluate their potential contribution to post-extraction wound healing. SHED were cultured and secretome was collected at passage 4, then purified. BMP-2 and TNF-α concentrations were measured using Enzyme-Linked Immunosorbent Assay (ELISA) in ten replicates. Data were analyzed for distribution, mean, and correlation. The results showed that BMP-2 concentrations ranged from 3.22 to 5.38 ng/mL (mean = 4.53 ± 0.62 ng/mL), while TNF-α ranged from 147.87 to 266.62 pg/mL (mean = 203.48 ± 38.08 pg/mL). Both analytes showed normal distribution. The mean BMP-2:TNF-α ratio was 0.023, indicating a pro-regenerative profile. No significant correlation was found between BMP-2 and TNF-α levels (r = 0.43, p = 0.22). The findings from this study showed that SHED secretome gel delivers consistent, osteo-inductive BMP-2 concentrations alongside controlled TNF-α levels, supporting a balanced environment for bone regeneration and inflammation resolution post-extraction. These findings highlight the potential of SHED secretome gel as a regenerative adjunct in dental wound healing.
No takes yet. Share an insight, caveat, or question.
Sa’adah et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: